Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter

Oncogene volume 21, pages 8862–8870 (2002)Cite this article

Abstract

The mammalian protein DEK has been implicated in multiple cellular processes, including transcriptional regulation, mRNA processing, and chromatin remodeling, and is associated with a number of clinical autoimmune and neoplastic conditions. The connection between DEK and cancer exists at multiple levels: (a) the t(6;9) chromosomal translocation that characterizes a subtype of acute myelogenous leukemia cases results in the formation of a DEK-CAN fusion oncoprotein; (b) a fragment of dek cDNA is capable of partially reversing the radiation-sensitive phenotype of fibroblasts cultured from ataxia-telangiectasia patients; and (c) increased levels of dek mRNA have been found to be associated with hepatocellular carcinoma, glioblastoma, and melanoma. Despite the growing list of cancer subtypes with a connection to DEK, the factors that mediate its expression have yet to be characterized. Here we undertake the analysis of DEK regulation by mapping the discrete elements within the proximal promoter that are responsible for constitutive transcription of dek in transformed cells. We find that functional elements include an inverted CCAAT box and a YY1 consensus binding site, and the introduction of point mutations into these sites markedly diminishes transcriptional activity. In addition, we identify the transcriptional activator NF-Y as a member of the CCAAT-binding complex, and verify binding of the transcription factor YY1 at its consensus site in the dek promoter. The discovery of NF-Y and YY1 as regulatory determinants of DEK expression is consistent with the well-documented roles of these two factors in cellular proliferation and transformation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Alexiadis V, Waldmann T, Andersen J, Mann M, Knippers R, Gruss C . 2000 Genes Dev. 14: 1308–1312

  • Aravind L, Koonin E . 2000 Trends Biochem. Sci. 25: 112–114

  • Arnaudo J, Deibener J, Kaminsky P . 1998 J. Rheumatol. 25: 1861–1862

  • Dignam J, Lebovitz R, Roeder R . 1983 Nucleic Acids Res. 11: 1475–1489

  • Dong X, Wang J, Kabir F, Shaw M, Reed A, Stein L, Andrade L, Trevisani V, Miller M, Fujii T, Akizuki M, Pachman L, Satoh M, Reeves W . 2000 Arthritis Rheum. 43: 85–93

  • Donohoe M, Zhang X, McGinnis L, Biggers J, Li E, Shi Y . 1999 Mol. Cell. Biol. 19: 7237–7244

  • Duan Z, Stamatoyannopoulos G, Li Q . 2001 Mol. Cell. Biol. 21: 3083–3095

  • Faulkner N, Hilfinger J, Markovitz D . 2001 J. Biol. Chem. 276: 25804–25812

  • Flanagan J . 1995 Cell Growth Differ. 6: 185–190

  • Fornerod M, Boer J, van Baal S, Jaegle M, von Lindern M, Murti K, Davis D, Bonten J, Buijs A, Grosveld G . 1995 Oncogene 10: 1739–1748

  • Fu G, Grosveld G, Markovitz D . 1997 Proc. Natl. Acad. Sci. USA 94: 1811–1815

  • Grottke C, Mantwill K, Dietal M, Schadendorf D, Lage H . 2000 Int. J. Cancer 88: 535–546

  • Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel A, Kel O, Ignatieva E, Ananko E, Podkolodnaya O, Kolpakov F, Podkolodny N, Kolchanov N . 1998 Nucleic Acids Res. 26: 362–367

  • Hu Q, Maity S . 2000 J. Biol. Chem. 275: 4435–4444

  • Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, Goseki N, Matsubara O, Takenaka K, Shichita M, Tanaka K, Shuda M, Yamamoto M . 1999 Cancer Res. 59: 4990–4996

  • Kroes R, Jastrow A, McLone M, Yamamoto H, Colley P, Kersey D, Yong V, Mkrdichian E, Cerullo L, Leestma J, Moskal J . 2000 Cancer Lett. 156: 191–198

  • Le Hir H, Izaurralde E, Maquat L, Moore M . 2000 EMBO J. 19: 6860–6869

  • Le Hir H, Gatfield D, Izaurralde E, Moore M . 2001 EMBO J. 20: 4987–4997

  • Li X, Hooft van Huijsduijnen R, Mantovani R, Benoist C, Mathis D . 1992 J. Biol. Chem. 267: 8984–8990

  • Mantovani R . 1998 Nucleic Acids Res. 26: 1135–1143

  • Mantovani R . 1999 Gene 239: 15–27

  • McGarvey T, Rosonina E, McCracken S, Li Q, Arnaout R, Mientjes E, Nickerson J, Awre D, Greenblatt J, Grosveld G, Blencowe B . 2000 J. Cell Biol. 150: 309–320

  • Meyn M, Lu-Kuo J, Herzing L . 1993 Am. J. Hum. Genet. 53: 1206–1216

  • Minuzzo M, Marchina S, Broggini M, Faircloth G, d'Incalci M, Mantovani R . 2000 Proc. Natl. Acad. Sci. USA 97: 6780–6784

  • Murray K, Szer W, Grom A, Donnelly P, Levinson J, Giannini E, Glass D, Szer I . 1997 J. Rheumatol. 24: 560–567

  • Petkova V, Romanowski M, Sulijoadikusumo I, Rohne D, Kang P, Shenk T, Usheva A . 2001 J. Biol. Chem. 276: 7932–7936

  • Shi Y, Lee J, Galvin K . 1997 Biochim. Biophys. Acta 1332: F49–F66

  • Shrivastava A, Calame K . 1994 Nucleic Acids Res. 22: 5151–5155

  • Sierakowska H, Williams K, Szer I, Szer W . 1993 Clin. Exp. Immunol. 94: 435–439

  • Tanaka H, Ohshima N, Hidaka H . 1999 Mol. Pharmacol. 55: 356–363

  • von Lindern M, Fornerod M, van Baal S, Jaegle M, de Wit T, Buijs A, Grosveld G . 1992 Mol. Cell. Biol. 12: 1687–1697

  • Zhou Y, Lee A . 1998 J. Natl. Cancer Inst. 90: 381–388

Download references

Acknowledgements

This work was supported by grants to DM Markovitz from the National Institutes of Health (AI 36685), the American Cancer Society and the Arthritis Foundation. KV Sitwala was supported in part by the National Institutes of Health training grant T32 GM07863 through the University of Michigan Medical Scientist Training Program.

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Program in Cellular and Molecular Biology, University of Michigan, 1150 West Medical Center Drive, Ann Arbor, 48109-0640, Michigan, MI, USA

    Kajal V Sitwala, Kristine Adams & David M Markovitz

Authors
  1. Kajal V Sitwala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristine Adams
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David M Markovitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David M Markovitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sitwala, K., Adams, K. & Markovitz, D. YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter. Oncogene 21, 8862–8870 (2002). https://doi.org/10.1038/sj.onc.1206041

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206041

Keywords

This article is cited by

Search

Advanced search

Quick links